# Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo

> **NCT05577637** · PHASE1 · COMPLETED · sponsor: **Combined Military Hospital Abbottabad** · enrollment: 60 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** 0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily

## Key facts

- **NCT ID:** NCT05577637
- **Lead sponsor:** Combined Military Hospital Abbottabad
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05577637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05577637, "Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05577637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*